BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29029100)

  • 21. Guidelines for transposition surgery and why we need them.
    Karl TR
    Eur J Cardiothorac Surg; 2017 Jan; 51(1):1. PubMed ID: 28077501
    [No Abstract]   [Full Text] [Related]  

  • 22. An audit to assess the impact of new directives about the use of aprotinin on re-exploration rates and blood product usage after adult cardiac surgery.
    Khan SA; Jayarajah M; Ahlijah B
    J Cardiothorac Vasc Anesth; 2009 Jun; 23(3):445-6. PubMed ID: 18834830
    [No Abstract]   [Full Text] [Related]  

  • 23. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery.
    Nakayama Y; Nakajima Y; Tanaka KA; Sessler DI; Maeda S; Iida J; Ogawa S; Mizobe T
    Br J Anaesth; 2015 Jan; 114(1):91-102. PubMed ID: 25303988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic drug treatment in the prevention of postoperative bleeding.
    Tyers GF
    Ann Thorac Surg; 1997 Mar; 63(3):912. PubMed ID: 9066438
    [No Abstract]   [Full Text] [Related]  

  • 25. [Strategy of transfusion in cardiac and aortic surgery].
    Trekova NA; Solovova LE; Gus'kov DA; Solov'eva IN; Markin AV; Goloborod'ko VG; Panin VV
    Anesteziol Reanimatol; 2014; (3):4-10. PubMed ID: 25306676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis.
    Alghamdi AA; Albanna MJ; Guru V; Brister SJ
    J Card Surg; 2006; 21(3):320-6. PubMed ID: 16684074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk and crisis management by anesthesiologists regarding 'Guidelines for Actions Against Intraoperative Critical Hemorrhage' published by the Japanese Society of Anesthesiologists and the Japan Society of Transfusion Medicine and Cell Therapy].
    Irita K; Yoshimura H; Sakaguchi Y; Takamatsu C; Tokuda K
    Masui; 2008 Sep; 57(9):1109-16. PubMed ID: 18807897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microfibrillar collagen hemostat in cardiac surgery.
    Robicsek F
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1228; author reply 1228. PubMed ID: 15052237
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of priming solution and ultrafiltration on post-operative bleeding and blood transfusion in cardiac surgery. Randomized controlled trial.
    Olmos Rodríguez M; Ballester Hernández JA; Arteta Bárcenas MT; Rodríguez Cerezo A; Vidarte Ortiz de Artiñano MA; Veiga Alameda C
    Rev Esp Anestesiol Reanim; 2015 Feb; 62(2):81-9. PubMed ID: 25048999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European Society of Cardiology guidelines: preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery.
    Kristensen SD
    J Cardiovasc Med (Hagerstown); 2011 Mar; 12(3):226. PubMed ID: 21285739
    [No Abstract]   [Full Text] [Related]  

  • 31. Perioperative Use of Coagulation Factor Concentrates in Patients Undergoing Cardiac Surgery.
    Smith MM; Ashikhmina E; Brinkman NJ; Barbara DW
    J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1810-1819. PubMed ID: 28838728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. eComment: Re: Multi-modality blood conservation strategy in open heart surgery: an audit.
    Bockeria LA; Grigoryants RG
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):482-3. PubMed ID: 19687048
    [No Abstract]   [Full Text] [Related]  

  • 33. An Interdisciplinary Education Initiative to Promote Blood Conservation in Cardiac Surgery.
    Goda TS; Sherrod B; Kindell L
    J Healthc Qual; 2017; 39(3):e33-e41. PubMed ID: 26087024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indications for labile blood products and the physiology of transfusion in surgery].
    Ozier Y; Mignon A; Rosencher N
    Transfus Clin Biol; 2005 Jun; 12(2):221-5. PubMed ID: 15950892
    [No Abstract]   [Full Text] [Related]  

  • 35. Current red blood cell transfusion practices.
    Goodnough LT
    AACN Clin Issues; 1996 May; 7(2):212-220. PubMed ID: 8718383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of a Multidisciplinary Bleeding and Transfusion Protocol Significantly Decreases Perioperative Blood Product Utilization and Improves Some Bleeding Outcomes.
    Timpa JG; O'Meara LC; Goldberg KG; Phillips JP; Crawford JH; Jackson KW; Alten JA
    J Extra Corpor Technol; 2016 Mar; 48(1):11-8. PubMed ID: 27134303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfusion: part of the perioperative blood transfusion and blood conservation management team.
    Baker RA; Dickinson TA; Shann KG; Likosky DS; Spiwak AB
    Ann Thorac Surg; 2008 Jan; 85(1):359; author reply 359-60. PubMed ID: 18154854
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased lactate load of older red blood cell preparations increases blood lactate concentrations in infants during cardiac surgery.
    Bojan M; Desplanque L; Albinni S
    Paediatr Anaesth; 2018 Feb; 28(2):185-186. PubMed ID: 29345089
    [No Abstract]   [Full Text] [Related]  

  • 40. Pillar 2: minimising bleeding and blood loss.
    Bisbe E; Moltó L
    Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):99-110. PubMed ID: 23590919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.